Answers are grounded in this paper and cite their sources.
Protocol describes developing a human intestinal model to study immune responses and HIV-1 infections.
The intestinal mucosa is a major HIV-1 infection site, making immune-augmented intestinal models essential for mechanistic and therapeutic studies. We present a protocol that converts human intestinal organoids into polarized 2D epithelial monolayers and incorporates basolateral dendritic cells to create a biomimetic intestinal mucosal model. We describe steps for monolayer formation, integrity assessment, immune cell co-culture, virus inoculation, and analyses by flow cytometry and confocal microscopy. This immuno-organoid platform enables controlled HIV-1 exposure with immunological and virological readouts. For complete details on the use and execution of this protocol, please refer to Rader et al. 1
No takes yet. Share an insight, caveat, or question.
Rader et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: